Vanguard Group Inc Synlogic, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.58 - $17.99 $461 - $14,302	795 Added 0.04%	2,243,586 $1.71 Million
Q1 2022 May 13, 2022	SELL	$1.63 - $2.55 $15,010 - $23,482	-9,209 Reduced 0.41%	2,242,791 $5.38 Million
Q4 2021 Feb 14, 2022	BUY	$2.27 - $3.0 $73,352 - $96,942	32,314 Added 1.46%	2,252,000 $5.45 Million
Q3 2021 Nov 12, 2021	BUY	$2.45 - $4.1 $1.21 Million - $2.02 Million	492,315 Added 28.5%	2,219,686 $6.77 Million
Q2 2021 Aug 13, 2021	BUY	$3.0 - $4.39 $5.18 Million - $7.58 Million	1,727,371 New	1,727,371 $6.72 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.